BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioVie's enterprise value was $526.35K on Nov 11, 2026, against -$13.67M a year earlier. Over the last 5 years it ranged from -$16.42M to $27.85B, with a median of $1.57B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $526.35K | – |
| 2025 | Dec 31, 2025 | -$16.23M | -111.7% |
| 2024 | Dec 31, 2024 | $139.11M | -97.0% |
| 2023 | Dec 29, 2023 | $4.63B | -80.2% |
| 2022 | Dec 30, 2022 | $23.43B | +109.0% |
| 2021 | Dec 31, 2021 | $11.21B | -53.5% |
| 2020 | Dec 31, 2020 | $24.09B | +1228.0% |
| 2019 | Dec 31, 2019 | $1.81B | +750.8% |
| 2018 | Dec 31, 2018 | $213.19M | -99.9% |
| 2017 | Dec 29, 2017 | $238.91B | +26.5% |
| 2016 | Dec 30, 2016 | $188.79B | – |
See a number that looks wrong?